60 Degrees Pharmaceuticals Inc
(SXTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 0 | 0 | 115 |
| Receivables | 0 | N/A | 0 | 0 | 146 |
| Inventories | 0 | N/A | 0 | 0 | 689 |
| Other current assets | 0 | 0 | 0 | 0 | 226 |
| TOTAL | $0 | $N/A | $0 | $0 | $1,177 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 148 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 109 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $257 |
| Total Assets | $0 | $N/A | $0 | $0 | $1,394 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 589 |
| TOTAL | $0 | $N/A | $0 | $0 | $635 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | 0 | 0 | 18,586 |
| Other Non-Current Liabilities | -3 | 0 | 3 | 3 | 314 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $18,900 |
| Total Liabilities | $0 | $N/A | $0 | $0 | $19,548 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 0 | 0 | 4,979 |
| Retained earnings | 0 | N/A | 0 | 0 | -22,633 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -500 |
| TOTAL | $0 | $N/A | $0 | $0 | $-18,154 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $1,394 |